NEW YORK, NY / ACCESSWIRE / October 20, 2023 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of CM Life Sciences III Inc. ("CM Life Sciences"), which was acquired by EQRx, Inc. ("EQRx") (NASDAQ:EQRX) on August 5, 2021. Investors who purchased CM Life Sciences and continue to hold EQRx to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/eqrx.
Investigation Details:
The investigation concerns whether CM Life Sciences failed to provide relevant information to its shareholders before the acquisition.
What's Next?
If you are aware of any facts relating to this investigation or purchased CM Life Sciences shares, you can assist this investigation by visiting the firm's site: bgandg.com/eqrx. You can also contact Peretz Bronstein or his law clerk and client relations manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660.
There is No Cost to You
We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman:
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Nathanson
332-239-2660 | [email protected]
SOURCE: Bronstein, Gewirtz & Grossman, LLC